Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thymus Neoplasms | 5 | 2022 | 270 | 0.730 |
Why?
|
Centrosome | 5 | 2004 | 209 | 0.580 |
Why?
|
Thymoma | 3 | 2022 | 185 | 0.510 |
Why?
|
Hallux | 1 | 2015 | 43 | 0.490 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 196 | 0.430 |
Why?
|
Epidural Neoplasms | 1 | 2012 | 23 | 0.400 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2020 | 1434 | 0.370 |
Why?
|
Lymphoma, AIDS-Related | 3 | 2009 | 79 | 0.350 |
Why?
|
Spinal Cord Compression | 1 | 2012 | 234 | 0.340 |
Why?
|
Leukemia | 4 | 2006 | 1522 | 0.340 |
Why?
|
Gastric Mucosa | 7 | 1989 | 602 | 0.320 |
Why?
|
Herpesvirus 4, Human | 6 | 2016 | 1078 | 0.320 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2009 | 175 | 0.310 |
Why?
|
Pancytopenia | 1 | 2009 | 101 | 0.300 |
Why?
|
Aneuploidy | 3 | 2003 | 578 | 0.300 |
Why?
|
Thoracic Vertebrae | 1 | 2012 | 614 | 0.290 |
Why?
|
Polymerase Chain Reaction | 5 | 2016 | 6069 | 0.280 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3797 | 0.270 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 272 | 0.270 |
Why?
|
Duodenal Ulcer | 7 | 1989 | 117 | 0.250 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2003 | 1560 | 0.250 |
Why?
|
Leukemic Infiltration | 1 | 2005 | 48 | 0.250 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2005 | 38 | 0.240 |
Why?
|
Herpesvirus 8, Human | 2 | 2009 | 254 | 0.230 |
Why?
|
Hodgkin Disease | 1 | 2012 | 1383 | 0.230 |
Why?
|
HIV Seropositivity | 1 | 2009 | 961 | 0.220 |
Why?
|
Blood Platelet Disorders | 1 | 2023 | 59 | 0.210 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 745 | 0.210 |
Why?
|
Gene Fusion | 1 | 2006 | 357 | 0.210 |
Why?
|
Ascites | 1 | 2005 | 336 | 0.210 |
Why?
|
Sarcoma, Myeloid | 1 | 2023 | 52 | 0.200 |
Why?
|
Fever | 2 | 2009 | 1603 | 0.190 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2005 | 2047 | 0.190 |
Why?
|
Fusion Proteins, bcr-abl | 3 | 2013 | 430 | 0.180 |
Why?
|
Chromosome Aberrations | 3 | 2018 | 1774 | 0.180 |
Why?
|
Immunohistochemistry | 9 | 2022 | 11022 | 0.180 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2020 | 1376 | 0.180 |
Why?
|
Arthritis | 1 | 2005 | 677 | 0.170 |
Why?
|
DNA, Viral | 2 | 2016 | 2199 | 0.170 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2005 | 617 | 0.160 |
Why?
|
Radioactive Pollutants | 1 | 2018 | 13 | 0.160 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2018 | 15 | 0.160 |
Why?
|
Prostaglandins E, Synthetic | 2 | 1989 | 14 | 0.160 |
Why?
|
Papillomaviridae | 1 | 2005 | 1141 | 0.150 |
Why?
|
16,16-Dimethylprostaglandin E2 | 2 | 1989 | 22 | 0.150 |
Why?
|
Stem Cell Transplantation | 2 | 2017 | 1602 | 0.150 |
Why?
|
Thiosulfates | 2 | 1989 | 52 | 0.150 |
Why?
|
Mitosis | 2 | 2003 | 1173 | 0.150 |
Why?
|
Germinal Center | 1 | 2020 | 379 | 0.150 |
Why?
|
Lymphoma, B-Cell | 3 | 2017 | 943 | 0.150 |
Why?
|
Histiocytosis, Sinus | 1 | 2018 | 45 | 0.150 |
Why?
|
Weight Loss | 1 | 2009 | 2710 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3646 | 0.140 |
Why?
|
Stomach Ulcer | 2 | 1988 | 118 | 0.140 |
Why?
|
Carcinoma in Situ | 1 | 2003 | 779 | 0.140 |
Why?
|
Cysteamine | 6 | 1989 | 24 | 0.140 |
Why?
|
Skin Neoplasms | 2 | 2015 | 5849 | 0.140 |
Why?
|
Leydig Cells | 1 | 2016 | 55 | 0.140 |
Why?
|
Knee Joint | 1 | 2005 | 1656 | 0.140 |
Why?
|
Scavenger Receptors, Class B | 1 | 2016 | 83 | 0.130 |
Why?
|
Chromosome Segregation | 3 | 2003 | 229 | 0.130 |
Why?
|
Microspheres | 3 | 2005 | 773 | 0.130 |
Why?
|
Rectal Neoplasms | 1 | 2005 | 1182 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2016 | 190 | 0.130 |
Why?
|
Adrenal Cortex | 1 | 2016 | 134 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2003 | 976 | 0.130 |
Why?
|
beta Catenin | 1 | 2021 | 1043 | 0.130 |
Why?
|
Lymphoma, T-Cell | 2 | 2014 | 309 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2021 | 1410 | 0.120 |
Why?
|
Staining and Labeling | 1 | 2019 | 1072 | 0.120 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4778 | 0.120 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2014 | 13 | 0.120 |
Why?
|
Rats, Inbred Strains | 12 | 1989 | 2077 | 0.120 |
Why?
|
Mediastinal Neoplasms | 1 | 2017 | 403 | 0.120 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2017 | 1646 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 540 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 3 | 2013 | 3737 | 0.120 |
Why?
|
Leukemia, T-Cell | 1 | 2014 | 102 | 0.120 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 93 | 0.110 |
Why?
|
Diagnosis, Differential | 7 | 2021 | 12976 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2016 | 2844 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2013 | 2423 | 0.110 |
Why?
|
Papillomavirus Infections | 1 | 2005 | 1640 | 0.100 |
Why?
|
Fatal Outcome | 2 | 2009 | 1831 | 0.100 |
Why?
|
Gastrointestinal Motility | 5 | 1989 | 235 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 616 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 916 | 0.100 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2013 | 80 | 0.100 |
Why?
|
Ovary | 1 | 2016 | 956 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1927 | 0.100 |
Why?
|
Mutation | 5 | 2023 | 30198 | 0.100 |
Why?
|
Leukemia, Myeloid | 3 | 2004 | 696 | 0.100 |
Why?
|
Humans | 55 | 2023 | 765968 | 0.100 |
Why?
|
Biotechnology | 2 | 2003 | 284 | 0.090 |
Why?
|
Antibodies | 1 | 2019 | 2417 | 0.090 |
Why?
|
Viral Matrix Proteins | 3 | 2016 | 192 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 995 | 0.090 |
Why?
|
Lipid Peroxides | 2 | 1987 | 73 | 0.090 |
Why?
|
Prostatic Neoplasms | 3 | 2003 | 11083 | 0.090 |
Why?
|
RNA, Messenger | 1 | 2006 | 12768 | 0.090 |
Why?
|
Automation | 2 | 2003 | 585 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4520 | 0.090 |
Why?
|
Neoplasms | 4 | 2016 | 22340 | 0.090 |
Why?
|
Antigens | 3 | 2001 | 1438 | 0.090 |
Why?
|
Peptide Initiation Factors | 2 | 2001 | 53 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 3 | 2009 | 526 | 0.080 |
Why?
|
Hypercholesterolemia | 1 | 2016 | 1149 | 0.080 |
Why?
|
Saline Solution, Hypertonic | 1 | 1989 | 116 | 0.080 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5783 | 0.080 |
Why?
|
Translocation, Genetic | 2 | 2006 | 1394 | 0.080 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2009 | 185 | 0.080 |
Why?
|
SRS-A | 1 | 1988 | 132 | 0.080 |
Why?
|
Molecular Biology | 2 | 2022 | 574 | 0.070 |
Why?
|
Bone Marrow | 3 | 2023 | 2921 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 2 | 2003 | 747 | 0.070 |
Why?
|
Ethanol | 4 | 1988 | 1323 | 0.070 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1133 | 0.070 |
Why?
|
Free Radicals | 1 | 1987 | 238 | 0.070 |
Why?
|
Catalase | 1 | 1987 | 216 | 0.070 |
Why?
|
Male | 26 | 2022 | 363698 | 0.070 |
Why?
|
Duodenum | 4 | 1989 | 495 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 961 | 0.070 |
Why?
|
Hematopoiesis, Extramedullary | 2 | 2016 | 53 | 0.070 |
Why?
|
Gene Dosage | 2 | 2018 | 1216 | 0.070 |
Why?
|
Antigens, CD | 2 | 2014 | 4025 | 0.070 |
Why?
|
Female | 33 | 2022 | 396112 | 0.060 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.060 |
Why?
|
alpha-Thalassemia | 1 | 2006 | 53 | 0.060 |
Why?
|
Plasma Cells | 1 | 2009 | 591 | 0.060 |
Why?
|
Purines | 1 | 2009 | 615 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 1987 | 593 | 0.060 |
Why?
|
Pancreatic Juice | 1 | 1985 | 60 | 0.060 |
Why?
|
Bile | 2 | 1985 | 300 | 0.060 |
Why?
|
Middle Aged | 16 | 2022 | 223009 | 0.060 |
Why?
|
Acute Disease | 4 | 2009 | 7232 | 0.060 |
Why?
|
Multiple Myeloma | 2 | 2013 | 5197 | 0.060 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2005 | 93 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 5995 | 0.060 |
Why?
|
Animals | 28 | 2023 | 168764 | 0.060 |
Why?
|
Hydrochloric Acid | 4 | 1988 | 76 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 1 | 2006 | 1306 | 0.060 |
Why?
|
Mycoplasma Infections | 1 | 2004 | 120 | 0.060 |
Why?
|
Point Mutation | 3 | 2006 | 1590 | 0.060 |
Why?
|
Nitriles | 3 | 1987 | 982 | 0.060 |
Why?
|
Tumor Virus Infections | 2 | 1997 | 440 | 0.060 |
Why?
|
Lung Diseases | 1 | 2014 | 1940 | 0.050 |
Why?
|
Sarcoma, Experimental | 1 | 2003 | 116 | 0.050 |
Why?
|
Signal Transduction | 5 | 2016 | 23601 | 0.050 |
Why?
|
Antioxidants | 2 | 1989 | 1670 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2005 | 385 | 0.050 |
Why?
|
Rats | 14 | 1989 | 23707 | 0.050 |
Why?
|
Immunoblotting | 2 | 2016 | 1644 | 0.050 |
Why?
|
Chromosome Breakage | 1 | 2003 | 159 | 0.050 |
Why?
|
DNA | 3 | 2023 | 7202 | 0.050 |
Why?
|
DNA Probes | 1 | 2003 | 541 | 0.050 |
Why?
|
Mice | 13 | 2023 | 81819 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6832 | 0.050 |
Why?
|
Immunoenzyme Techniques | 3 | 2001 | 1701 | 0.050 |
Why?
|
Aged | 11 | 2022 | 171117 | 0.050 |
Why?
|
Cell Division | 3 | 2004 | 4475 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2016 | 2942 | 0.050 |
Why?
|
Eukaryotic Initiation Factor-2 | 2 | 2001 | 177 | 0.050 |
Why?
|
Adult | 14 | 2022 | 223044 | 0.050 |
Why?
|
E2F6 Transcription Factor | 1 | 2021 | 2 | 0.050 |
Why?
|
Microcirculation | 1 | 1986 | 1280 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 9601 | 0.050 |
Why?
|
Cyclins | 1 | 2004 | 598 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2005 | 1602 | 0.050 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 350 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2022 | 59489 | 0.050 |
Why?
|
Gene Amplification | 1 | 2006 | 1091 | 0.050 |
Why?
|
Liver | 2 | 2016 | 7562 | 0.050 |
Why?
|
Survival Rate | 4 | 2017 | 12795 | 0.050 |
Why?
|
Racemases and Epimerases | 1 | 2001 | 113 | 0.040 |
Why?
|
Lymphoma | 1 | 1990 | 1897 | 0.040 |
Why?
|
Loss of Heterozygosity | 2 | 2018 | 663 | 0.040 |
Why?
|
Pancreatitis | 1 | 2007 | 1087 | 0.040 |
Why?
|
DNA Helicases | 1 | 2006 | 852 | 0.040 |
Why?
|
Scleroderma, Systemic | 1 | 2004 | 346 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 1742 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2003 | 5526 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 197 | 0.040 |
Why?
|
Epirizole | 2 | 1989 | 3 | 0.040 |
Why?
|
Splenomegaly | 2 | 2016 | 192 | 0.040 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2003 | 392 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 629 | 0.040 |
Why?
|
Sodium Hydroxide | 3 | 1987 | 37 | 0.040 |
Why?
|
Gastric Acid | 4 | 1987 | 98 | 0.040 |
Why?
|
Intestine, Small | 2 | 2004 | 1214 | 0.040 |
Why?
|
HIV Infections | 1 | 2005 | 17533 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2022 | 497 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4562 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2003 | 1107 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 354 | 0.040 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2019 | 135 | 0.040 |
Why?
|
Ukraine | 1 | 2018 | 151 | 0.040 |
Why?
|
Biopsy, Needle | 3 | 2007 | 1628 | 0.040 |
Why?
|
Transplantation, Heterologous | 3 | 2016 | 2394 | 0.040 |
Why?
|
Hypohidrosis | 1 | 1998 | 29 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14652 | 0.040 |
Why?
|
Herpesviridae Infections | 2 | 1997 | 268 | 0.040 |
Why?
|
Calreticulin | 1 | 2018 | 111 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1745 | 0.040 |
Why?
|
Immunotoxins | 2 | 1997 | 177 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1240 | 0.040 |
Why?
|
Splenic Rupture | 1 | 1997 | 25 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2018 | 157 | 0.040 |
Why?
|
Leukocytes | 1 | 2005 | 2027 | 0.030 |
Why?
|
Prognosis | 3 | 2023 | 29922 | 0.030 |
Why?
|
Reticulocytosis | 1 | 2016 | 10 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2023 | 1789 | 0.030 |
Why?
|
Anemia, Macrocytic | 1 | 2016 | 54 | 0.030 |
Why?
|
Cadherins | 1 | 2021 | 900 | 0.030 |
Why?
|
Receptors, Lipoprotein | 1 | 2016 | 87 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2009 | 3078 | 0.030 |
Why?
|
Sweat Gland Neoplasms | 1 | 1998 | 110 | 0.030 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 116 | 0.030 |
Why?
|
Sjogren's Syndrome | 1 | 1998 | 239 | 0.030 |
Why?
|
Celiac Disease | 1 | 2004 | 820 | 0.030 |
Why?
|
Aspirin | 1 | 1987 | 3134 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 647 | 0.030 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 1996 | 49 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2012 | 17594 | 0.030 |
Why?
|
Myelodysplastic Syndromes | 1 | 2006 | 1404 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2019 | 2627 | 0.030 |
Why?
|
Autoantibodies | 1 | 2004 | 2113 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2003 | 21056 | 0.030 |
Why?
|
Forearm | 1 | 2018 | 427 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2007 | 2226 | 0.030 |
Why?
|
Thrombocytosis | 1 | 1996 | 87 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 1490 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 562 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1884 | 0.030 |
Why?
|
Equipment Design | 1 | 2003 | 3481 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2016 | 419 | 0.030 |
Why?
|
Blood Donors | 1 | 1997 | 342 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 1998 | 423 | 0.030 |
Why?
|
Pruritus | 1 | 1998 | 378 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 1996 | 527 | 0.030 |
Why?
|
NF-kappa B | 2 | 2009 | 2485 | 0.030 |
Why?
|
Cell Line | 3 | 2019 | 15543 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1997 | 633 | 0.030 |
Why?
|
Phytohemagglutinins | 1 | 1994 | 164 | 0.030 |
Why?
|
Base Sequence | 4 | 2012 | 12403 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2599 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2476 | 0.030 |
Why?
|
Frozen Sections | 1 | 2014 | 153 | 0.030 |
Why?
|
Primary Myelofibrosis | 1 | 1996 | 210 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2014 | 301 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3344 | 0.030 |
Why?
|
Coronary Occlusion | 1 | 2016 | 283 | 0.030 |
Why?
|
Alopecia | 1 | 1998 | 414 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2505 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 1998 | 6113 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 1994 | 253 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5696 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2012 | 101 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 59889 | 0.030 |
Why?
|
Stem Cells | 1 | 2005 | 3540 | 0.030 |
Why?
|
Cell Survival | 1 | 2002 | 5747 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3430 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 1994 | 561 | 0.020 |
Why?
|
NIH 3T3 Cells | 2 | 2004 | 651 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1886 | 0.020 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 76 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 674 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 870 | 0.020 |
Why?
|
Immunologic Factors | 2 | 2007 | 1587 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
Risk Assessment | 2 | 2003 | 24282 | 0.020 |
Why?
|
Pyridines | 3 | 1989 | 2888 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10261 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 1989 | 1127 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2120 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4405 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 1930 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 752 | 0.020 |
Why?
|
Thorax | 1 | 2014 | 554 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2630 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2016 | 1458 | 0.020 |
Why?
|
Sodium Radioisotopes | 1 | 1989 | 6 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 13024 | 0.020 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 1990 | 24 | 0.020 |
Why?
|
Carcinoma | 1 | 2001 | 2312 | 0.020 |
Why?
|
Parvoviridae Infections | 1 | 1990 | 39 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 870 | 0.020 |
Why?
|
Blood Platelets | 1 | 2001 | 2464 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1998 | 2203 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-4E | 2 | 2001 | 111 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2589 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2721 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2009 | 164 | 0.020 |
Why?
|
Gastric Emptying | 2 | 1988 | 247 | 0.020 |
Why?
|
Bicarbonates | 2 | 1987 | 293 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1652 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1171 | 0.020 |
Why?
|
Time Factors | 4 | 2003 | 40065 | 0.020 |
Why?
|
Retina | 1 | 2019 | 2657 | 0.020 |
Why?
|
Phenotype | 2 | 2001 | 16721 | 0.020 |
Why?
|
Phenothiazines | 1 | 1988 | 60 | 0.020 |
Why?
|
Pyrazoles | 2 | 1989 | 2033 | 0.020 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1988 | 93 | 0.020 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9249 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2832 | 0.020 |
Why?
|
Transcription Factors | 2 | 2004 | 12131 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1315 | 0.020 |
Why?
|
Apoptosis | 2 | 2003 | 9514 | 0.020 |
Why?
|
Cell Cycle | 2 | 2009 | 2920 | 0.020 |
Why?
|
Capillary Permeability | 2 | 1988 | 768 | 0.020 |
Why?
|
Tissue Donors | 1 | 1997 | 2395 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1994 | 1896 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3421 | 0.020 |
Why?
|
Burkitt Lymphoma | 1 | 2009 | 338 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2003 | 5881 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81514 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 1986 | 1478 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1192 | 0.020 |
Why?
|
Child | 3 | 2003 | 80564 | 0.020 |
Why?
|
Ethanolamine | 1 | 1985 | 9 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 18973 | 0.020 |
Why?
|
Rheology | 1 | 1986 | 348 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2016 | 11641 | 0.020 |
Why?
|
Stomach Diseases | 1 | 1986 | 134 | 0.020 |
Why?
|
Taurocholic Acid | 1 | 1985 | 43 | 0.020 |
Why?
|
Gastric Juice | 1 | 1985 | 59 | 0.020 |
Why?
|
Pepsin A | 1 | 1985 | 64 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2003 | 20124 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 1985 | 66 | 0.010 |
Why?
|
Common Bile Duct | 1 | 1985 | 106 | 0.010 |
Why?
|
Mucus | 1 | 1987 | 346 | 0.010 |
Why?
|
Pylorus | 1 | 1985 | 86 | 0.010 |
Why?
|
Ultrasonography | 1 | 2018 | 5993 | 0.010 |
Why?
|
Ethanolamines | 1 | 1985 | 152 | 0.010 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 691 | 0.010 |
Why?
|
Artificial Gene Fusion | 1 | 2004 | 57 | 0.010 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2004 | 42 | 0.010 |
Why?
|
Intestinal Secretions | 1 | 1984 | 15 | 0.010 |
Why?
|
Mycoplasma | 1 | 2004 | 144 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3681 | 0.010 |
Why?
|
Ligation | 1 | 1985 | 444 | 0.010 |
Why?
|
Transcription Factor AP-2 | 1 | 2004 | 78 | 0.010 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 3 | 1989 | 88 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
Disease Progression | 1 | 2001 | 13632 | 0.010 |
Why?
|
Hematopoietic System | 1 | 2003 | 110 | 0.010 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2004 | 155 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9373 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 772 | 0.010 |
Why?
|
Capillaries | 1 | 1986 | 755 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2004 | 269 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 2009 | 22332 | 0.010 |
Why?
|
Interleukin-7 | 1 | 2003 | 147 | 0.010 |
Why?
|
Blotting, Western | 2 | 2001 | 5020 | 0.010 |
Why?
|
Acetylcholine | 1 | 1985 | 626 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1565 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 372 | 0.010 |
Why?
|
Models, Animal | 1 | 2009 | 2120 | 0.010 |
Why?
|
Electrodes | 1 | 1985 | 609 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 71 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1990 | 2412 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1997 | 4270 | 0.010 |
Why?
|
Sequence Deletion | 2 | 1997 | 1495 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6763 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2003 | 444 | 0.010 |
Why?
|
Coronary Disease | 1 | 2016 | 5912 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2003 | 449 | 0.010 |
Why?
|
Retroviridae | 1 | 2004 | 847 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4772 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 360 | 0.010 |
Why?
|
Cytochalasin B | 1 | 2001 | 74 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 2001 | 113 | 0.010 |
Why?
|
Nocodazole | 1 | 2001 | 95 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2001 | 187 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 440 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2003 | 9550 | 0.010 |
Why?
|
Detergents | 1 | 2001 | 235 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39193 | 0.010 |
Why?
|
Dyneins | 1 | 2001 | 126 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1984 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41649 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1985 | 1206 | 0.010 |
Why?
|
Keratins | 1 | 2001 | 498 | 0.010 |
Why?
|
Autoantigens | 1 | 2004 | 883 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2001 | 812 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2391 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 1998 | 9071 | 0.010 |
Why?
|
Electromyography | 1 | 1985 | 1399 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 2001 | 419 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 2825 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2003 | 722 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2745 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2163 | 0.010 |
Why?
|
Fasting | 1 | 1985 | 1606 | 0.010 |
Why?
|
Proteomics | 1 | 2012 | 3910 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 1997 | 5753 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2003 | 13400 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2007 | 2132 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15398 | 0.010 |
Why?
|
CHO Cells | 1 | 2001 | 1372 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 839 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1673 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4348 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 2001 | 769 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2004 | 888 | 0.010 |
Why?
|
Glomerulonephritis, IGA | 1 | 1997 | 62 | 0.010 |
Why?
|
Hemoperitoneum | 1 | 1997 | 38 | 0.010 |
Why?
|
Cricetinae | 1 | 2001 | 2411 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6544 | 0.010 |
Why?
|
Leukapheresis | 1 | 1997 | 150 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 1987 | 18293 | 0.010 |
Why?
|
Autoimmunity | 1 | 2004 | 1354 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 1997 | 359 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1985 | 10729 | 0.010 |
Why?
|
Cytoplasm | 1 | 2001 | 1500 | 0.010 |
Why?
|
Intestinal Mucosa | 2 | 2004 | 3046 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 17075 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5743 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11868 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2001 | 1066 | 0.010 |
Why?
|
Splenectomy | 1 | 1997 | 390 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6220 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2060 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1987 | 2592 | 0.010 |
Why?
|
Microtubules | 1 | 2001 | 1062 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1997 | 15747 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 1996 | 209 | 0.010 |
Why?
|
Half-Life | 1 | 1996 | 644 | 0.010 |
Why?
|
Virus Latency | 1 | 1997 | 360 | 0.010 |
Why?
|
Amino Acids | 1 | 2001 | 1709 | 0.010 |
Why?
|
Hemorrhage | 1 | 1986 | 3461 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2004 | 1892 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2086 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1996 | 435 | 0.010 |
Why?
|
Pneumothorax | 1 | 1997 | 392 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 88835 | 0.010 |
Why?
|
Prostate | 1 | 2001 | 1755 | 0.010 |
Why?
|
Fibroblasts | 1 | 2004 | 4159 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1997 | 1740 | 0.010 |
Why?
|
Living Donors | 1 | 1997 | 645 | 0.010 |
Why?
|
Collagen | 1 | 2001 | 2618 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1997 | 689 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4908 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1996 | 2171 | 0.010 |
Why?
|
Selection, Genetic | 1 | 1996 | 878 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1996 | 1866 | 0.010 |
Why?
|
Parvoviridae | 1 | 1990 | 7 | 0.010 |
Why?
|
Calcium | 1 | 2003 | 5767 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1997 | 2729 | 0.000 |
Why?
|
Protein Structure, Tertiary | 1 | 1996 | 3750 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1997 | 4860 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 2 | 2004 | 20659 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2003 | 14448 | 0.000 |
Why?
|
Pancreas | 2 | 1985 | 1700 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1999 | 3454 | 0.000 |
Why?
|
Benzene Derivatives | 1 | 1987 | 51 | 0.000 |
Why?
|
Malondialdehyde | 1 | 1987 | 112 | 0.000 |
Why?
|
Injections, Subcutaneous | 1 | 1988 | 682 | 0.000 |
Why?
|
United States | 1 | 2014 | 72903 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15880 | 0.000 |
Why?
|
Ergolines | 1 | 1985 | 55 | 0.000 |
Why?
|
Bromocriptine | 1 | 1985 | 93 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7478 | 0.000 |
Why?
|
Amylases | 1 | 1985 | 171 | 0.000 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1985 | 152 | 0.000 |
Why?
|
Trypsin | 1 | 1985 | 487 | 0.000 |
Why?
|
Prostaglandins | 1 | 1986 | 396 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9443 | 0.000 |
Why?
|
Recurrence | 1 | 1997 | 8501 | 0.000 |
Why?
|
Spleen | 1 | 1990 | 2296 | 0.000 |
Why?
|
Genetic Variation | 1 | 1997 | 6610 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1994 | 5125 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 65188 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1988 | 4850 | 0.000 |
Why?
|
Electrodes, Implanted | 1 | 1984 | 830 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1990 | 3211 | 0.000 |
Why?
|
Ischemia | 1 | 1987 | 1909 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13648 | 0.000 |
Why?
|
Chronic Disease | 1 | 1988 | 9347 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 36532 | 0.000 |
Why?
|